Have a feature idea you'd love to see implemented?
Let us know!
APLT Applied Therapeutics Inc
Price (delayed)
$0.8801
Market cap
$102.41M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.46
Enterprise value
$5.51M
Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company's lead drug candidate,
Highlights
The equity has surged by 153% year-on-year but it has dropped by 92% since the previous quarter
APLT's revenue has dropped by 102% year-on-year but it is up by 37% since the previous quarter
The company's net income has shrunk by 94% YoY and by 16% QoQ
The company's EPS fell by 24% YoY
Key stats
What are the main financial stats of APLT
Market
Valuations
Earnings
Shares outstanding
116.36M
Market cap
$102.41M
Enterprise value
$5.51M
Price to earnings (P/E)
N/A
Price to book (P/B)
17.15
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
-$211,000
Gross profit
-$211,000
Net income
-$187.31M
EBIT
-$187.31M
EBITDA
-$186.96M
Free cash flow
-$81.84M
Per share
Balance sheet
Liquidity
EPS
-$1.46
EPS diluted
-$1.61
Free cash flow per share
-$0.57
Book value per share
$0.05
Revenue per share
$0
TBVPS
$0.74
Total assets
$106.57M
Total liabilities
$100.67M
Debt
$1.97M
Equity
$5.89M
Working capital
$5.64M
Debt to equity
0.33
Current ratio
1.06
Quick ratio
1
Net debt/EBITDA
0.52
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-170.1%
Return on equity
-583.4%
Return on invested capital
N/A
Return on capital employed
-2,464.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
APLT stock price
How has the Applied Therapeutics stock price performed over time
Intraday
-13.72%
1 week
-23.47%
1 month
-90.67%
1 year
-70.27%
YTD
-73.73%
QTD
-89.65%
Financial performance
How have Applied Therapeutics's revenue and profit performed over time
Revenue
-$211,000
Gross profit
-$211,000
Operating income
-$92.28M
Net income
-$187.31M
Gross margin
N/A
Net margin
N/A
APLT's revenue has dropped by 102% year-on-year but it is up by 37% since the previous quarter
The company's gross profit has shrunk by 102% YoY but it rose by 37% QoQ
The company's net income has shrunk by 94% YoY and by 16% QoQ
Applied Therapeutics's operating income has decreased by 48% YoY and by 18% from the previous quarter
Growth
What is Applied Therapeutics's growth rate over time
Valuation
What is Applied Therapeutics stock price valuation
P/E
N/A
P/B
17.15
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS fell by 24% YoY
The equity has surged by 153% year-on-year but it has dropped by 92% since the previous quarter
APLT's price to book (P/B) is 9% more than its 5-year quarterly average of 15.8
APLT's revenue has dropped by 102% year-on-year but it is up by 37% since the previous quarter
Efficiency
How efficient is Applied Therapeutics business performance
The return on assets has increased by 31% year-on-year
Dividends
What is APLT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for APLT.
Financial health
How did Applied Therapeutics financials performed over time
The company's total assets is 6% higher than its total liabilities
The company's total assets has surged by 136% YoY but it fell by 17% QoQ
The total liabilities has soared by 82% from the previous quarter and by 79% YoY
APLT's debt is 67% smaller than its equity
The equity has surged by 153% year-on-year but it has dropped by 92% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.